Targeting the proper amyloid-beta neuronal toxins: a path forward for Alzheimer’s disease immunotherapeutics

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1758-9193
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Targeting the proper amyloid-beta neuronal toxins: a path forward for Alzheimer’s disease immunotherapeutics ; volume:6 ; number:4 ; day:9 ; month:7 ; year:2014 ; pages:1-15 ; date:8.2014
Alzheimer's research & therapy ; 6, Heft 4 (9.7.2014), 1-15, 8.2014

Urheber
Goure, William F.
Beteiligte Personen und Organisationen
Krafft, Grant A.
Jerecic, Jasna
Hefti, Franz
SpringerLink (Online service)

DOI
10.1186/alzrt272
URN
urn:nbn:de:1111-2016073131938
Rechteinformation
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 10:50 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Goure, William F.
  • Krafft, Grant A.
  • Jerecic, Jasna
  • Hefti, Franz
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Soluble amyloid-beta isoforms predict downstream Alzheimer’s disease pathology

Soluble amyloid-beta isoforms predict downstream Alzheimer’s disease pathology

Amyloid-beta and phosphorylated tau in post-mortem Alzheimer’s disease retinas

Amyloid-beta and phosphorylated tau in post-mortem Alzheimer’s disease retinas

Pyroglutamate and Isoaspartate modified Amyloid-Beta in ageing and Alzheimer’s disease

Pyroglutamate and Isoaspartate modified Amyloid-Beta in ageing and Alzheimer’s disease

Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers

Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers

Astroglial Responses to Amyloid-Beta Progression in a Mouse Model of Alzheimer’s Disease

Astroglial Responses to Amyloid-Beta Progression in a Mouse Model of Alzheimer’s Disease

Amyloid-beta uptake by blood monocytes is reduced with ageing and Alzheimer’s disease

Amyloid-beta uptake by blood monocytes is reduced with ageing and Alzheimer’s disease

Pathological changes induced by Alzheimer’s brain inoculation in amyloid-beta plaque-bearing mice

Pathological changes induced by Alzheimer’s brain inoculation in amyloid-beta plaque-bearing mice

Rolle des alpha2-Makroglobulin beim proteolytischen Abbau des Alzheimer Amyloid-beta

Hochschulschrift

Rolle des alpha2-Makroglobulin beim proteolytischen Abbau des Alzheimer Amyloid-beta

Molekulare Pathomechanismen Phosphorylierter Amyloid-beta (Aβ)-peptide in der Alzheimer-Krankheit

Hochschulschrift

Molekulare Pathomechanismen Phosphorylierter Amyloid-beta (Aβ)-peptide in der Alzheimer-Krankheit

Quantitative characterization of amyloid-beta interaction with artificial compounds designed for Alzheimer´s disease therapy

Quantitative characterization of amyloid-beta interaction with artificial compounds designed for Alzheimer´s disease therapy

Noncanonical regulation of imprinted gene Igf2 by amyloid-beta 1–42 in Alzheimer’s disease

Noncanonical regulation of imprinted gene Igf2 by amyloid-beta 1–42 in Alzheimer’s disease

Different associations between amyloid-βeta 42, amyloid-βeta 40, and amyloid-βeta 42/40 with soluble phosphorylated-tau and disease burden in Alzheimer’s disease: a cerebrospinal fluid and fluorodeoxyglucose-positron emission tomography study

Different associations between amyloid-βeta 42, amyloid-βeta 40, and amyloid-βeta 42/40 with soluble phosphorylated-tau and disease burden in Alzheimer’s disease: a cerebrospinal fluid and fluorodeoxyglucose-positron emission tomography study

Verbundene Objekte